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1. Purpose and Introduction.
The purpose of this thesis is to provide a description of the
characteristics of marijuana-dependent treatment-seeking adults through a
review of the literature. In addition, findings from a multi-site clinical
treatment trial for marijuana dependence will be presented. Although
several previous studies have described the characteristics of marijuana
treatment-seeking adults (Budney et al., 1996; Stephens, Roffman, &
Curtain, in press; Stephens, Roffman, & Simpson, 1993), the present study
is the largest of its type and the first to specifically target culturally and
economically diverse individuals, as well as women. A primary aim of this
paper is to examine the characteristics of individuals who were eligible for
the Marijuana Treatment Project and chose not to participate in relation to
the characteristics of those who did participate in the trial. Another goal is
to describe the demographic as well as clinical characteristics of the sample,
including frequency of marijuana use and severity of dependence.
Integration of findings based on the client characteristics in the current
multi-site trial along with those of earlier studies should be helpful in the
development of future relevant and effective treatment programs for primary
marijuana dependence.
Marijuana is the most commonly used illicit substance in the United
States. According to the Summary of Findings from the 1998 National
Household Survey on Drug Abuse, there are 11 million marijuana users who
smoked in the past month (SAMHSA, 1999). Marijuana use is often thought
to be associated with the abuse of other drugs and alcohol. However, several
recent studies have shown that there is a group of individuals who seek
substance abuse treatment with marijuana as their primary drug of abuse.
In the past decade, there has been an increased interest in identifying the
"pure" marijuana user, as well as assessing the need for marijuana specific
treatment (Hall & Babor, in press; Roffman & Barnhart, 1987; Stephens,
Roffman, & Simpson, 1993; Zweben & O’Connell, 1992).
2. Background.
Following is a description of marijuana, a review of the epidemiology
of marijuana use, a review of the available clinical research, and a
description of the Cannabis Dependence syndrome. Finally, data from
several earlier studies describing characteristics of marijuana-dependent
treatment-seeking individuals are reviewed.
2.1. Description ofMarijuana. The term marijuana is commonly used
to refer to the smokable part (i.e., the flowering tops and leaves) of the
cannabis plant. Cannabis sativa L., the hemp plant, is the most prevalent
strain in the United States and grows wild throughout the tropical and
temperate regions of the world. Cannabis contains numerous chemicals
called cannabinoids that are unique to the cannabis plant. The most well
known of these cannabinoids, delta-9-tetrahydrocannabinol (THC), is
thought to be responsible for the characteristic psychoactive effects of
cannabis. The THC content of any given strain of illicit marijuana varies. In
the early 1970’s, the average THC concentration was less than 1%. The
current range is from 7% to as much as 17% in sensimilla, the seedless and
most prevalent form of marijuana (Hall, 1995). These higher concentrations
of THC in marijuana may contribute the likelihood that individuals may
become dependent. Though it is most commonly smoked, marijuana can be
consumed by eating or even drinking the cannabis products.
2.2. Epidemiology. After a decline in the number of new users since
1975, the incidence of marijuana use has been on the rise since 1991.
According to recent data from the National Household Survey on Drug
Abuse, there were 2.5 million new users of marijuana in 1996. These data
also show that the age of new users has been getting younger and younger
each year. That is, in 1996 the annual age-specific rate of first use per
1,000 person-years of exposure was 83.2. In 1993 it was 53.9, the highest it
had been for 10 years. In addition, the mean age of onset has steadily
decreased from 19 years old to 16 years old since 1986 (SAMHSA, 1998).
Nationally, marijuana is the most common non-prescription drug being used
today and accounts for 81% of all illicit drug use. Of the almost 14 million
illicit drug users surveyed, 81% used marijuana. The majority of these,
(60%) used marijuana exclusively, while 21% combined their marijuana use
with some other drug (SAMHSA, 1999).
When comparing data from the state of Connecticut to national data,
the statistics on marijuana use are similar. Marijuana is also the most
commonly used illicit drug in the state of Connecticut. Approximately one in
three Connecticut residents have tried marijuana at least once in his or her
life, and approximately 3% reported use in the past month (Ungemack et al.,
1999).
National and state drug abuse surveys provide information about use
patterns including the more severe pattern of dependence characterized by a
chronic pattern of use associated with psychological, physiological, and
4social problems related to marijuana use. In the 1996 Adult Household
Survey of Connecticut, 3.9% of 18-25 year olds met the criteria for current
Cannabis Dependence, the national equivalent was slightly higher at 4.9%.
For 26-34 year olds, 1.2% of Connecticut residents was currently dependent
on marijuana, whereas 1.6% was reported nationally. For those who were
35 years or older 0.1% reported current dependence in Connecticut versus
0.3% nationally (Ungemack et al., 1999).
Despite these rates, treatment for marijuana dependence is not being
sought at the same rate. Findings from the National Treatment
Improvement Evaluation Study found that most marijuana users in drug
treatment are there for cocaine and alcohol dependence, whereas marijuana-
only users represent just 6% of those in treatment (Wisdom, 1999).
Connecticut state data are consistent with national data. Only 3% of
individuals presenting for substance abuse treatment identified marijuana
as their primary drug of abuse (Ungemack, Laube, & Babor, 1995).
However, because of differences in sampling frames surveys,
measures of treatment use and need can vary greatly. General population
research can be inadequate in covering crucial population groups residing
within the sampled areas. For instance, individuals living in jails,
residential treatment facilities, university and military housing,
convalescence or elderly homes, in addition to homeless populations
represent an increasing percentage of the United States population not being
surveyed for treatment need. In addition, alcohol and drug abuse tend to be
widespread with these individuals (Schmidt & Weisner, 1999).
2.3. Clinical Research. Despite the prevalence of chronic marijuana
use described in epidemiological data sets, there is relatively little systematic
understanding about the characteristics of dependent individuals and the
pattern of problems experienced by these individuals. While individuals who
use marijuana infrequently may resemble the occasional drinker, and not
experience problems related to its use, users who cascade into dependence
may indeed suffer a constellation of negative consequences as a result of
their smoking behavior (Hall & Babor, in press; Stephens & Roffman, 1996).
There are a number of plausible explanations for the lack of research
in this area. One is the common perception that marijuana is a benign drug
and chronic use does not pose a health threat. Another rationale for the
lack of empirical studies stems the common misconception that marijuana
does not produce physiological dependence, and the consequences of its use
are not as threatening as alcohol or other psychoactive drugs. To the
contrary, regular users have reported many concerns, among them, cognitive
deficits such as memory and concentration loss, or problems with thinking
(Solowij, 1998). Individuals who consider themselves dependent also report
relationship difficulties with family members and friends. Employment
problems and psychological issues such as lack of self-esteem and
motivation are also among the many cited concerns for users, as are health
problems (Stephens, Roffman, & Simpson, 1993). Marijuana is most often
smoked, which puts the user at greater risk of respiratory diseases.
Cannabis smoke is quantitatively very similar in composition to tobacco
smoke. Thus, it is likely that chronic marijuana use will cause similar lung
diseases such as bronchitis, or cancer (Hall, 1995; Tashkin, 1999). A recent
epidemiological study found evidence that chronic marijuana use may
increase the risk of head and neck cancer with a strong dose-response
pattern (Zhang et al., 1999).
Physiological withdrawal symptoms resulting from marijuana use
were often believed to be of relatively low intensity (Roffman et al., 1988).
And it was often perceived that if withdrawal symptoms did occur, it was
because of concurrent involvement with other substances. In fact, many
previous studies (Rainone et al., 1987) found it difficult to isolate the heavy
marijuana user who was not concurrently using other drugs. These studies
were unable to separate the polydrug user from those who did manifest a
Cannabis Dependence syndrome independent of other drug or alcohol use
problems. However, recent studies have now begun to document that
individuals may develop both physiological and psychological dependencies
on cannabis, and that cessation from use may produce a withdrawal
syndrome broadly characterized by anxiety, restlessness, sleep disturbance
and appetite change (Budney, Nory, & Hughes, 1999; Jones, Benowitz, &
Herning, 1981; Weisbeck et al., 1996). Although the Diagnostic and
Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) of the
American Psychiatric Association (1994), states that Cannabis Dependence
is often seen in the absence of tolerance or withdrawal symptoms, this
theory is being challenged by accumulating evidence to suggest a true
physiological withdrawal syndrome exists. Thus, tolerance to cannabis-
induced effects can indeed occur (Compton, Dewey, & Martin, 1990; Jones,
Benowitz, & Herning, 1981).
More recent attention to the concept of Cannabis Dependence and
treatment may be due to a number of emerging arguments. Changes in
cultural attitudes toward illicit drug use as well as the social and
physiological side effects of marijuana use (Zweben & O’Connell, 1992) may
be influencing this shift. New workplace policies including drug testing are
creating environments in which marijuana use is not only prohibited but
also monitored. In order to maintain their employment, many marijuana
users who are unable to stop smoking are seeking help from treatment
facilities. In one study designed to assess the need for Cannabis
Dependence treatment, individuals were asked to respond to an
advertisement if they were concerned about their marijuana use.
Investigators found that 92% said that they would be interested in
participating in a treatment program designed specifically for marijuana
users. The study also indicated that only 18.2% of the respondents had ever
been treated for drug abuse in the past, suggesting a fair degree of unmet
treatment needs (Roffman & Barnhart, 1987).
2.4. Cannabis Dependence Syndrome. Despite previous beliefs that
marijuana may not produce a dependence syndrome, there is increasing
evidence to suggest that individuals who exhibit a chronic pattern of use
develop a substance-related disorder characterized by psychological,
physiological, and social problems related to their smoking (Budney, Nory, &
Hughes, 1999; Stephens, Roffman, & Simpson, 1993).
The criteria that comprise the Substance-Related disorders are
described in the Diagnostic and Statistical Manual of Mental Disorders,
Fourth Edition (DSM-IV). The essential features of Substance Dependence
can be applied to each of ten classes of drugs including alcohol,
amphetamines, cannabis, cocaine, hallucinogens, inhalants, nicotine,
opioids, phencyclidine, and sedatives. The syndrome is defined by a
combination of physiological, cognitive, and behavioral symptoms. These
symptoms are indicative of an individual’s continued use despite the
knowledge of significant problems resulting from the substance use.
Dependence can also be exhibited by a pattern of repeated drug use that
results in tolerance, withdrawal, and continued compulsive use.
In a field trial designed to examine cross-system agreement for
substance-use disorders, Rounsaville et al. (1993) investigated diagnoses
based on DSM-III-R, DSM-IV and the latest version of the International
Classification of Diseases (ICD-10). Findings from the study indicated that
heavy marijuana use was not characterized as consistently as other drugs by
the elements of the dependence syndrome. The authors noted that this is
most likely due to the fact that marijuana is not associated with a "rush" of
sensations that would encourage the user to develop compulsive use. Also,
marijuana is usually not associated with the extreme withdrawal symptoms
that are typically the basis for relief use. Thus, the gradual onset of effect
and elimination of THC is not as likely to promote the compulsive behaviors
associated with drugs like cocaine or opioids. Nonetheless, the authors
recommend retaining the identical dependence syndrome criteria for
Cannabis Dependence noting that differences across substances will be
reflected in the number of symptoms endorsed by heavy users.
With these caveats in mind, Cannabis Dependence may be described
as a maladaptive pattern of use, accompanied by significant clinical
impairment or distress as manifested by at least three of the following seven
symptoms coexisting in a 12-month period. (1) Tolerance: Tolerance is
described as the need to smoke more marijuana in order to get high, or
achieve a desired effect. In other words, smoking the usual amount does not
produce the previously desired "high". (2) Withdrawal: The presence of
marijuana-specific withdrawal symptoms (e.g., irritability, agitation, anxiety,
craving, sleep difficulty, headaches, nausea, etc.) as the result of stopping or
cutting down use of marijuana. Withdrawal also may be identified by an
individual’s smoking marijuana in order to avoid or relieve the
uncomfortable symptoms of withdrawal. (3) Compulsion: Marijuana is used
for a longer period of time or in greater amounts than intended. For
example, someone may intend to take only one hit, and end up smoking the
whole joint to the point of severe intoxication. (4)Compulsion is also
demonstrated when the time spent buying marijuana, using marijuana or
recovering from its effects are such that most of the day is taken up by these
activities. (5) Re-addiction Liability: There are often unsuccessful attempts
or persistent desires to quit or cut down. (6) Salience: Marijuana use takes
up the time (or reduces the time) normally spent on meaningful occupational
activities, recreational activities, or social activities. (7)Salience can also be
exhibited by continued smoking despite a persistent or recurrent
psychological or physical problem that was most likely caused or worsened
by marijuana use (e.g., a nagging cough, or memory loss). This criterion
does not focus on the content or presence of a particular problem or
impairment, but rather the individual’s knowledge that marijuana use and
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the subsequent failure to abstain from smoking cause the problem
(American Psychiatric Association, 1994).
2.5. Characteristics ofMarijuana-Dependent Treatment-Seeking
Individuals. There have been a few studies that have examined the
characteristics of treatment-seeking marijuana-dependent adults. Roffman
and Barnhart (1987) conducted one study that assessed the need for
marijuana specific treatment through a telephone survey. Individuals in this
study were not clinically assessed for dependence, but rather recruited
based on their concern about their chronic marijuana use. They were later
assessed for problems associated with their use and their desire for
marijuana treatment. As a result of the high response rate to the study,
Stephens, Roffman, and Simpson (1993) conducted a follow-up study at the
University of Washington that examined the efficacy of attracting and
intervening with adult marijuana users. Budney et al. (1999) conducted a
study that considered the effectiveness of interventions incorporating
cognitive and contingent reinforcement techniques for marijuana
dependence.
The samples in these studies were found to reflect similar
demographic characteristics. The average participant was 32 years old,
white, and male. The telephone screening procedure versus the treatment
study in Washington showed respectively that 44% and 40% of the
interested participants were married, 38% and 46% were single, and 12%
and 13% were divorced, while Budney’s study showed 50% had never been
married. The level of education attained by the participants varied by study,
however, this may be a function of how the studies were promoted. Only
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50% of Budney’s participants completed some education beyond high
school, whereas the phone screen attracted 91% who had 12 or more years
of education, and the treatment study recruited 78% with at least a high
school education. Although the treatment study did not indicate the
employment status of their participants, the telephone sample and Budney’s
sample attracted mostly employed individuals (79% and 65% respectively).
The largely similar distributions across demographic categories lend support
for a tentative profile of the typical chronic marijuana user.
These studies found that marijuana treatment-seeking individuals
reported a number of adverse psychological, physiological and social
consequences, as a result of chronic use. These consequences included
relationship difficulties with family and friends, legal, employment and
financial problems, health problems, and cognitive impairments. Stephens,
Roffman, and Simpson (1993) found that the most common problem
reported in the sample was the inability to stop smoking (93%). The next
most commonly reported problems were negative feelings about abuse (87%),
procrastination (86%), and a decrease in self-confidence (76%). Memory loss
was a concern for 67% of the sample. Other worries included experiencing
unpleasant withdrawal symptoms (51%), family problems (47%), financial
difficulty (41%), decreased work/school performance (15%), and legal trouble
(3%). Roffman and Barnhart (1987) found that similar problems were of
concern for their participants as well, although in their study, self-reported
cognitive problems ranked highest. Self-esteem, health, family
relationships, and financial problems were next among the most noted
adverse consequences associated with their use of marijuana.
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Budney’s sample (1999} had been chronic smokers for an average of
15 years and met 6.4 of the 9 dependence criteria (71%) as outlined in DSM-
III-R. They also smoked about four times a day on roughly 75% of the days
in the month prior to intake. Similarly, the treated sample in Washington
(Stephens, Roffman, & Simpson, 1994} found that their sample had been
smoking regularly for 15 years. They smoked marijuana about 2.7 times a
day on 81 of the past 90 days. Consistent with national data, these trials
reported that their participants began smoking regularly at about age 16 or
17 (Budney et al., 1999; Roffman & Barnhart, 1987; Stephens, Roffman, &
Simpson, 1993).
Stephens, Roffman and Curtain (in press) recently conducted a study
comparing extended and brief interventions for marijuana use. The
demographic and marijuana use characteristics are remarkably similar to
the previous treatment study by Stephens, Roffman and Simpson (1994).
3. Methodology.
3.1. Description ofthe Marijuana Treatment Project. The Marijuana
Treatment Project (MTP), otherwise known as the Multi-site Study of the
Effectiveness of Brief Treatment for Cannabis Dependence, was a three-year,
randomized clinical trial that investigated the effectiveness of brief
interventions for adults with Cannabis Dependence. The project, funded by
the Center for Substance Abuse Treatment (SAMHSA-CSAT) in October of
1996, was a cooperative agreement with three recruitment sites and one
coordinating center. The recruitment sites were located in Farmington, CT,
Miami, FL, and Seattle, WA, with a Coordinating Center also located in
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Farmington, CT. The primary goal of MTP was to compare two brief
treatments for Cannabis-Dependent individuals from differing socio-
economic and racial backgrounds.
The research battery began with a telephone screening interview, and
further in-person, or face-to-face evaluations were carried out at intake into
the study, at the end of treatment, and at 4, 9 and 15 months post
randomization.
3.2. Study Design. Although the primary goal of the Marijuana
Treatment Project was to evaluate treatment effectiveness, the purpose of
this study was to describe the characteristics of the marijuana-dependent
treatment-seeking adults who were randomized into the Marijuana
Treatment Project. In addition, those who were eligible for the study, but
who declined participation, were examined in relation to trial participants.
Telephone screening and intake data were utilized to examine the
hypothesis that there is a distinct group of treatment-seeking adults who are
dependent solely on marijuana. More specifically, these individuals vary in
gender, ethnicity, and employment status although other studies (Budney et
al., 1996; Stephens, Roffman, & Curtin, in press; Stephens, Roffman, &
Simpson, 1994) have suggested that marijuana treatment seekers tend to be
primarily Caucasian, male, and employed. Subjects were classified from the
screening data according to study participation. Eligible study participants
who volunteered for the MTP were compared to eligible subjects who
declined study participation and treatment. These groups were compared on
a variety of measures including demographic information, marijuana use
history and alcohol and other drug use. Further examination of the final
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MTP sample including analyses by gender, ethnicity, and employment status
was done to provide data relevant to the implementation of treatment
programs and to address access needs of individuals seeking treatment.
3.3. Subject Recruitment. Recruitment for the Marijuana Treatment
Project took place between May of 1997 and August of 1998, primarily
through media advertisements. The ads targeted adults who were interested
in receiving free treatment to help them quit or reduce their heavy marijuana
use.
A telephone screening questionnaire (the Quick Screen) was
administered to interested subjects to determine preliminary eligibility for
the study. If a participant appeared to meet the inclusion criteria, a baseline
interview was scheduled in-person to review the eligibility criteria and
determine the participant’s appropriateness for the study. If deemed
appropriate (i.e., met the inclusion criteria, willing to accept randomization,
and interested in participating), the subject was asked to sign an informed
consent form and complete the baseline assessment battery.
A total of 1,211 interested callers were screened over the telephone
during the sixteen-month recruitment period. The three treatment sites
collectively recruited 450 eligible participants for the trial (Farmington, CT
recruited 155, Seattle, WA recruited 146, and Miami, FL recruited 149), and
elicited a final subject pool of 308 men and 142 women. Of the remaining
761 screened, 398 were ineligible, while 363 individuals were eligible at the
time of the screening but declined the opportunity to participate or did not
attend the face-to-face baseline interview.
15
3.4. Inclusion and Exclusion Criteria. Potential participants for the
MTP were required to meet certain criteria for inclusion in the study.
Individuals had to be at least 18 years old to participate. They had to have
smoked marijuana on at least 40 of the 90 days prior to the interview, and
had to meet the diagnosis of current Cannabis Dependence as described in
the DSM-IV. Those who were currently dependent on another drug or
alcohol, as defined in the DSM-IV were excluded as were those who
indicated a need for immediate treatment that would not allow for
randomization into the delayed-treatment control group. Acute medical or
psychiatric problems were exclusionary criteria as they might interfere with
the MTP treatment. Those who were currently receiving treatment for a drug
or alcohol problem or regularly attending a 12-step fellowship program were
also excluded from the study. Finally, individuals were not eligible to
participate in MTP if the legal system had mandated drug treatment or urine
screening as part of their sentencing or probation.
Certain logistical variables were also examined to ensure that
participation in the treatment and research protocol would not be
compromised. Subjects were required to have access to reliable
transportation and live within 60 miles of the treatment clinic. In addition,
potential subjects could not be planning to move in the near future.
Participants were excluded if they could not identify a locator to assist in
follow-up tracking. Additionally, individuals were required to understand
English well enough to participate meaningfully in the treatment, although
they were not excluded for the inability to read or write in English.
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3.5. Baseline (Intake) Assessments. The initial appointment for the
participant was a two-part assessment designed to elicit objective data, as
well as self-report information. It was comprised of two components; a
diagnostic component designed to review the eligibility criteria and a pre-
treatment component for those who were seen as eligible for the study.
Interviewer-administered assessments and self-report questionnaires were
utilized as the primary methods of obtaining intake data.
Table 1 outlines the assessments administered to MTP participants
that were utilized for this paper. Both the alcohol and drug modules of the
Structured Clinical Interview for DSM-IV, also known as the SCID (First et
al., 1996) was used to further determine an individual’s eligibility for the
MTP. This interview assesses each of the seven dependence criteria for
drugs, including sedatives, stimulants, opiates, cocaine, hallucinogens,
inhalants and cannabis, as well as alcohol. Individuals were required to
meet the diagnosis of Cannabis Dependence. In addition, the SCID was
used to indicate whether a participant met the criteria for dependence on
alcohol or other drugs which would make them ineligible for the study.
Three additional instruments comprised the pre-treatment component
of the baseline evaluation. These included the Addiction Severity Index
(McLellan et al., 1992) the Time Line Follow-Back interview (Sobell & Sobell,
1992), and a short treatment services utilization questionnaire. The
Addiction Severity Index (ASI) was used to collect information about
circumstances in the subject’s life which may have had an impact on, or be
affected by, their substance abuse problem. The major areas of assessment
included severity indices of the participant’s alcohol and drug use status,
17
medical status, employment and support status, legal status, social
relationships and psychiatric status.
The Time Line Follow-Back (TLFB) is an instrument originally
designed to aid research participants in the recall of their daily drinking
routine. The structure of this interview was modified to accommodate a
marijuana use pattern instead. The TLFB adapted for the Marijuana
Treatment Project was used to assess the participant’s marijuana use by
employing calendar prompts for a specific time frame (i.e., the last 90 days).
The interviewer and the participant worked together to evaluate the pattern
of smoking by the participant. This was done by completing a calendar, first
with key dates, idiosyncratic events, weekly events, holidays, or special
events which my have helped the individual in remembering his or her
marijuana use pattern. Then the participant was asked to recall marijuana
use with regard to specific quadrants of the day. That is, whether or not the
participant smoked in the morning, afternoon, evening or nighttime. In
addition to how often individuals smoked, participants were also asked to
remember whether or not they used alcohol or other drugs on those days.
Once the calendar portion of this instrument was completed, the
participants were also asked questions about their use of marijuana in
hazardous situations (e.g., while driving a car or taking care of children).
A short treatment services utilization questionnaire was used to
evaluate subjects’ use of general medical, drug and alcohol treatment, and
psychiatric services, both inpatient and outpatient in the past 90 days. In
addition, medication use was recorded as were other social services utilized
in the last 90 days.
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Participants were also asked to complete a battery of self-report
questionnaires. These included: 1) The Beck Depression Inventory (Beck et
al., 1961). The BDI includes 21 symptoms and attitudes that are common
among depressed psychiatric patients. These items are rated on a scale of 0-
3 in intensity and summed. The higher the score, the more severe the level
of depression in the patient. 2) The State-Trait Anxiety Inventory (State)
(Spielberger et al., 1983). The STAI-State is a measure of anxiety that is
used to assess current emotional experience. Each of the 20 items is based
on a weighted 4-point scale ("almost never" to "almost always"), resulting in
a range from 20 (low anxiety) to 80 (high anxiety). 3) The Marijuana
Problem Scale (Stephens et al., 1994). The MPS was designed to include
recent (i.e., last 90 days) problems associated with cannabis use. The 19
items are rated by the participant as "not a problem", as a "minor problem",
or as a "major problem". For MTP research purposes, the number of
problems endorsed (whether a minor or major problem) were simply summed
for a range of 0-19. A number of additional self-report assessments were
administered at the baseline interview for the MTP, but were not used in
these analyses.
3.6. Data Analysis. The data were collected and entered on site using
SPSS Data Entry. Each assessment was entered and then verified before
being sent to the centralized coordinating center where the data from all
three sites were merged. The data were then checked for logical
inconsistencies, anomalies, and missing values. Pearson chi-square tests of
independence were used to determine the significance of association
between categorical variables. Independent-Samples T Tests were used to
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test difference among the means of two-group samples while One-Way
Analysis of Variance (ANOVA)was used to test differences among the means
of the three-group samples. Levene’s test for homogeneity of variance was
utilized for testing the assumption that the groups’ variances were equal.
When ANOVA tests were significant, LSD post hoc tests were employed to
determine where differences lie. The SPSS default of .05 significance level
was used and missing data were handled on a case by case basis.
4. Results.
4.1. Characteristics ofEligible Individuals. Of the 1,211 persons
screened for the Marijuana Treatment Project, this study focuses on the 813
individuals deemed eligible at the time of the telephone screening process.
Of those, 363 (45%) decided not to participate in the project while 450 (55%)
were successfully recruited into the study. This sample describes a group of
individuals who were interested in a treatment program designed specifically
for those who are marijuana dependent. Table 2 shows that these
individuals were primarily male (68%), and on average, 35 years old. Sixty-
five percent of the group was White, while 15.6% was African American and
16.5% was Hispanic. Sixty-five percent of the sample was unmarried, and
approximately half (56%) lived in a rented house or apartment. Individuals
in this group had, on average, 14 years of education. Sixty-four percent
worked full-time, 14% worked part-time, and 16% were unemployed. Those
who did work had been employed at their current job for approximately five
20
Drug use data in Table 3 show that marijuana use was the primary
concern for these individuals. Eighty-seven percent felt that they were
currently dependent on marijuana. Only 16% of the sample reported past
dependence on alcohol, while 22% reported past dependence on a drug other
than marijuana. At the time of the screening, almost the entire sample
(99%) felt that marijuana was the biggest problem for them (relative to
alcohol or other substances). The group reported smoking marijuana on 81
of the past 90 days (90% of the days), and smoked an average of 3.8 times a
day. They reported drinking alcohol an average of two drinks per drinking
day, and rarely drank more than 5 drinks in a sitting (.93 days in the past
month). Use of other drugs in the past 30 days was also infrequent,
although it should be noted that current alcohol and other drug dependence
were reasons for exclusion. Sedatives and cocaine were used on average .20
days, opiate use, 11 days, stimulants were used on .04 days, and heroin
was used on .02 days. Use of Methadone or intravenous drugs are not
reported, as both were exclusion criteria.
In order to prevent the study’s findings from being contaminated by
mediating factors, anyone who was receiving psychiatric treatment for
alcohol or other drug problems, including AA meeting attendance at the time
of the study initiation, was excluded from participation. In addition, anyone
who had a chronic psychiatric or medical problem that required
hospitalization was excluded. However, general outpatient psychiatric
counseling was permitted. Table 4 shows that a small proportion (8%) of
those eligible for participation were currently receiving treatment for a
psychiatric problem. Just fewer than 8% had been hospitalized in the past
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for a psychiatric problem, and 6% indicated that they had serious thoughts
of suicide in the past 90 days.
4.2. Characteristics ofEligible Individuals Who Declined Participation
(DP) vs. MTP Participants. In an effort to identify potential barriers for
individuals who might benefit from treatment, the 363 individuals who were
considered eligible at the time of the telephone screen but chose not to
participate in the Marijuana Treatment Program were compared to the 450
participants enrolled in the study. Table 5 highlights the demographic
characteristics that were significantly different for the study participation
groups (DP vs. MTP). Treatment participation was shown to be associated
with ethnic group and social stability. Particularly, African American callers
were less likely to participate in the study. Although they were interested in
treatment, many failed to show for their baseline interview or declined
participation in the study (20.2% DP vs. 12.0% MTP; 17.72, p<.01).
Those who were unmarried were more likely to decline participation or not
show for their baseline interview (70.8% DP vs. 59.8% MTP; 10.56,
p<.01). Participants in MTP were more likely to own or live in a family owned
residence (45.8% MTP vs. 36.4% DP; -=7.82, p<.05) and were less likely to
be unemployed (12.4% MTP vs. 21.3% DP; =19.30, p<.01).
In addition, those who declined participation were, on average, two
years younger than those in the MTP (33.78 DP vs. 36.08 MTP; t=-3.69,
p<.01). The non-participators had fewer years of education (13.30 DP vs.
14.04 MTP; t=--5.03, p<.01), were employed in their current job for fewer
years (4.04 DP vs. 5.03 MTP; t=-2.13, p<.05), and had moved more times in
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the past year (.78 DP vs..47 MTP, t=4.00, p<.01) than those who did
participate.
The decision to participate in the study was associated with the
response to the question "Are you currently dependent on marijuana?"
Table 6 shows that 91.6% of the MTP participants said that they were
currently dependent on marijuana while only 81.4% of the non-participators
indicated that they were dependent ( =22.10, p<.01). Those who decided
not to participate drank more alcohol drinks per drinking day than the MTP
participants (2.29 vs. 1.85 respectively, t=2.94, p<.01). Further, those who
participated in the MTP were less likely to have used sedatives (t 2.20,
p<.05) or cocaine (t=3.02, p<.01) in the past 30 days, suggesting that MTP
attracted a ’purer" marijuana smoking group.
Variables that might normally be assumed to be associated with study
participation but were not were recruitment location, gender, lifetime
dependence on alcohol or other drugs, and lifetime or current psychiatric
problem (including suicidal ideation). Marijuana smoking pattern, including
the number of days smoked in the past 90, the number of times smoked per
day, and the number of days since the last smoking episode were also
similar across the two groups.
4.3. Characteristics ofMTP Participants. The following sections
examine characteristics from the final randomized sample of the Marijuana
Treatment Project. Because these individuals were enrolled in the study, a
more extensive assessment battery was collected for them.
4.3a. Demographic Characteristics. Thirty-two percent of the final 450
MTP participants were female. Table 5 illustrates those participants enrolled
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in the Marijuana Treatment Project. The three recruitment locations
collectively attracted a diverse sample. Overall, twelve percent of the final
sample were African American and 17% of the sample were Hispanic. The
Seattle, WA site recruited mostly White participants. Eighty-five percent of
their sample was White. Forty-one percent of the Miami, FL sample was
Hispanic, and 20% of the Farmington, CT sample was African American.
The mean age of the study sample was 36 years. The majority of
participants were employed full-time (69%), while 14% were employed part-
time, and 17% were unemployed (including students, homemakers, retired
individuals). Those who were working had been employed at their current
job for an average of five years. Sixty percent of the sample were not married
and 52% lived in a rented house or apartment, whereas 46% lived in their
own or a family owned house. The mean number of years of education for
the MTP group was 14.
4.3b. Marijuana Use and Treatment History. MTP participants
reported few lifetime treatment episodes; 82% had never received treatment
for drug abuse and 93% had never received treatment for alcohol abuse.
Intake data from the sample of 450 subjects showed that the MTP
participants smoked marijuana, on average, 80 out of the last 90 days, and
were high, on average, more than 6 and a half hours during a day. They
smoked approximately three standard sized joints per day and used about
three-eighths of an ounce of marijuana per week. The group indicated
having smoked marijuana regularly (i.e., three or more times per week) for
approximately 18 years, and reported that it had caused problems for them
for over nine years.
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4.3c. Dependence Criteria. Because there have been relatively few
clinical studies of chronic marijuana smokers, a goal of the MTP was to
carefully document the reported dependence symptoms through the use of a
structured clinical interview. Of the seven DSM-IV dependence criteria for
Cannabis Dependence, participants in the study were diagnosed, on
average, with 5.6 of the symptoms.
Table 7 lists the DSM-IV criteria for marijuana dependence and the
percentage of individuals who endorsed each criterion as reported on the
SCID. A large proportion of individuals experienced tolerance (68%) and
withdrawal (78%) symptomatology. A substantial majority reported a
compulsion to use marijuana with 77% using in larger amounts or over a
longer period of time than they intended, and 83% spending a great deal of
time getting, using and recovering from the effects of marijuana. In addition,
96% of the sample reported a persistent desire or unsuccessful attempts to
quit, cut down, or control their marijuana use.
While 64% reported that marijuana took up much of the time
normally spent on other activities, almost the entire sample (95%) reported
that they continued using marijuana despite knowing that it caused
persistent or recurrent psychological problems (e.g., excessive sedation,
decreased motivation, depression, anxiety, decreased concentration or
memory problems) or physical problems (e.g., chronic colds, coughs, or
asthma).
4.3d. Problem Measures. The Marijuana Treatment Project employed
a relatively new instrument to assess the number of problems marijuana has
caused the participants. The Marijuana Problem Scale, developed by
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Stephens et al. (1994) was designed to look at specific problems someone
might incur as the result of long-term marijuana use. These problems may
be personal (e.g., memory loss), social (e.g., problems between you and your
partner), or occupational (e.g., to have lower productivity). For this study,
the instrument was used to assess 19 items that may have been considered
a problem within the baseline period.
Table 8 shows the percentage of the sample that endorsed each
problem item as either a minor problem or a major problem. Overall, the
average number of problems endorsed was 9.6. Most commonly noted, 90%
of the sample felt badly about their use, 86% felt that marijuana caused
them to procrastinate or to have a lower energy level. Seventy-six percent of
the sample felt that marijuana had caused them to experience memory loss,
75% thought their marijuana use resulted in lower productivity, and 74%
thought it decreased their self-esteem. Also endorsed by the majority of
participants was the feeling that marijuana caused a lack of self-confidence
(68%), produced withdrawal symptoms (61%), and caused problems with
their partner (58%).
4.3e. Hazardous Use. The Marijuana Treatment Project examined the
assumption that marijuana has few negative consequences associated with
its use. Five hazardous use questions (Table 9) were designed to examine
the frequency of marijuana use within one hour prior to a number of
common activities in which using marijuana might put the user or others at
risk of injury. Those activities were: a) driving an automobile, b) taking care
of children, c) operating dangerous equipment, d) working on a paid job, and
e) playing sports or recreating. It is important to note that these percentages
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do not reflect the actual frequency in which the subject participated in the
activity.
Overall, 54% of the sample was under the influence of marijuana
while driving on a daily or almost daily basis, and 31% used marijuana daily
while operating other dangerous equipment. Seventeen percent of the
sample reported using marijuana before taking care of children on a daily
basis. For those employed, 40% reported smoking every day within one
hour of working on a paid job. Approximately 20% used marijuana in
conjunction with sporting or recreational activities on a daily or almost daily
basis.
4.3f. Analyses by Gender, Ethnicity, and Employment Status. As part
of this study’s initiative, there was a special effort to specifically target
culturally and economically diverse samples including women. The following
section will look at quantity and frequency of marijuana use as well as
severity of use for these target groups. There were no significant differences
in marijuana or other drug use, as well as lifetime treatment history for drug
or alcohol abuse across gender. However, females in our sample had
significantly higher values for the Addiction Severity Index composite scores.
They experienced more psychiatric problems (. 19 Females vs.. 13 Males; t
3.21, p<.01), medical problems (.27 Females vs..21 Males; t=--2.03, p<.05},
employment problems (.27 Females vs..20 Males; t=-3.16, p<.01), and drug
problems (.26 Females vs..24 Males; t=-2.34, p<.05), than the men in our
sample. The women in our sample also scored higher on the Beck
Depression Inventory (12.74 Females vs. 10.85 Males; t=-2.38, p<.05),
indicating overall higher levels of depression than did men. Women in our
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sample spent significantly more days with a psychiatric counselor (1.09
Females vs..53 Males; t=-2.13, p<.05), and took medication for psychiatric
problems on more days (14.20 Females vs. 6.54 Males; t=-2.68, p<.01), and
medical problems on more days (21.72 Females vs. 14.20 Males; t=-2.25,
p<.05), than the men. Table 10 highlights these significant findings across
gender.
Also of note, gender was found to be associated with driving under the
influence of marijuana. 60% of the men in the sample, versus 43% of the
women (2 15.44, p<.01) reported driving daily or almost daily while high.
Significant differences across ethnicity emerged relative to marijuana
and other drug use during the 90 days prior to the baseline interview (Table
11). Though ethnic groups reported similar rates of alcohol use (i.e., days of
alcohol use), Hispanics reported significantly higher levels of consumption
(i.e., number of drinks per drinking day) than did Whites (2.50 Hispanics vs.
1.84 Whites; F=4.73, p<.01). Hispanics also used other drugs on
significantly more days than African Americans (1.78 Hispanics vs..42
African Americans; F=-3.35, p<.05). The marijuana use variables from the
Time Line Follow-Back Interview revealed some differences between ethnic
groups. Whites were high for more hours of the day than either of the other
two groups (7.04 Whites vs. 5.55 African Americans, 5.74 Hispanics; F=-4.22,
p<.05), yet Hispanics used marijuana on more days (of the 90 day time
period) than the other two groups (83.17 Hispanics vs. 79.40 Whites, 75.47
African Americans; F=4.66, p<.05).
Hispanic members of the sample reported that although they did not
begin using marijuana at an earlier age than Whites and African Americans,
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marijuana caused them problems earlier in their smoking careers (23.31
Hispanics vs. 27.46 Whites, 28.44 African Americans; F=-7.87, p<.01). The
ASI Employment composite score showed that African Americans in our
study experienced more employment problems than did either of the other
two groups (.30 African Americans vs..21 Whites, .22 Hispanics; R=-4.65,
p<.05).
With regard to past treatment experiences, differences across
ethnicity were significant for the number of days using medications for a
medical problem. Whites, on average used medications at a significantly
higher rate than Hispanics (19.51 Whites vs. 8.35 Hispanics; F=-4.55, p<.05).
Marijuana and other drug use variables, including lifetime treatment
for alcohol or other drugs did not differ significantly across employment
condition. In addition, other treatment variables including, hospitalizations,
medication use and other psychiatric treatment did not differ across groups,
with the exception of the number of days seen for medical care. Those who
were unemployed saw a medical practitioner on more days (in the past 90)
than those who worked full time (7.08 Unemployed vs. 1.79 Employed FT;
F=-3.39, p<.05). Those who were unemployed also scored higher than both
employed groups on the ASI Medical composite score (.43 Unemployed vs.
.24 Employed PT, .20 Employed FT; F=- 16.11, p<.01).
Severity measures, however, did differ between employment groups
(Table 12). Those who were unemployed scored higher than the employed
groups on the Beck Depression Inventory (15.52 Unemployed vs. 12.07
Employed PT, 10.63 Employed FT; F=-10.10, p<.01). Full time employed
individuals scored significantly lower than the other two groups on the State
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Anxiety Inventory (38.42 Employed FT vs. 42.10 Employed PT, 43.94
Unemployed; F=6.80, p<.01), the MarijuanaProblem Scale (9.23 Employed
vs. 10.57 Employed PT, 10.48 Unemployed; F=5.84, p<.01), and the ASI
Psychiatric composite score (. 13 Employed FT vs.. 19 Employed PT, .24
Unemployed; F 12.24, p<.01). Not surprisingly, all groups differed from the
other on the ASI Employment composite score. Those unemployed scored
the most severe and those employed full time reported the fewest
employment problems (. 14 Employed FT vs..31 Employed PT vs..53
Unemployed; F 161.64, p<.01). Age of regular or problem marijuana use did
not differ between groups, and the number of dependence problems as
reported on the SCID also did not differ between the groups.
5. Summary and Discussion.
Over a decade ago, Roffman and Barnhart (1987) initiated exploration
of chronic marijuana users (i.e., who were not abusing alcohol or other
drugs), the problems associated with long-term use, and their willingness to
engage in treatment. This was the first step in examining a population of
dependent marijuana smokers. A further study indicated that not only did a
group of heavy marijuana smokers exist, but that they felt dependent on the
drug, and were looking for marijuana specific treatments to help them quit
(Stephens, Roffman, & Simpson, 1993). With the prevalence rate of current
marijuana use on the rise since the early 1990’s, and with the knowledge
that many of these individuals were interested in treatment for their
dependence, additional studies were conducted to examine treatment
efficacy (Budney et al., 1999; Stephens, Roffman, & Curtin, in press;
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Stephens, Roffman, & Simpson, 1994). Unlike previous studies of its kind,
the Marijuana Treatment Project is the largest study and the first multi-site
study to specifically target culturally and economically diverse individuals as
well as women. This paper has shown that, although previous studies have
been limited in recruiting primarily Caucasian men, MTP was effective in
attracting greater numbers of Non-Whites (31%) and females (32%).
5.1. Rationale for Marijuana-Specific Treatment. The number of callers
interested in the MTP study, indicated that there is a substantial group of
heavy marijuana users who are concerned about their use. In addition,
previous studies have shown that, if a marijuana-specific treatment program
is offered, individuals experiencing problems with their marijuana use will
be drawn to participate. Most of these individuals have not sought
treatment before. Although data pertaining to lifetime treatment episodes
were restricted to the final randomized sample, participants reported few
prior treatment episodes for drug abuse (.31). Among the reasons for this
may be due to the fact that there were virtually no marijuana-specific
treatment programs available to them. Most of the screened sample were
not co-dependent on other drugs or alcohol. In fact only 25% of the entire
screened sample was ineligible due to concurrent drug or alcohol therapy
and only 31% were excluded because of current dependence on another
drug or alcohol. These two groups were not mutually exclusive. Individuals
with primary marijuana dependence may not feel that they belong in the
same treatment program as those dependent on substances such as alcohol,
cocaine, or heroin. They may feel that their marijuana problem is not
important enough to warrant special focus, an attitude that may be
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conveyed by substance abuse facilities that view certain drugs as more
serious.
Participants screened for participation in the Marijuana Treatment
Project were about 35 years old and functioning at a relatively normal level
in society. Almost two-thirds were employed full-time and had an average
education level of 14 years despite smoking approximately 4 times a day for
many years. Demographic characteristics from the final MTP sample
indicated that unlike previous studies, this study was able to attract females
as well as minority individuals for participation in a marijuana specific
treatment program. Similar to other studies, the large majority of
participants were employed. In addition, 40% were married, and 46% lived
in their own home (or family owned home) which indicated a high level of
socio-economic stability for this group. In addition, the findings suggest
minimal levels of general psychiatric or other substance co-morbidity.
5.2. Barriers to Treatment Participation. Once individuals were
screened as potentially eligible based on the Quick Screen information, a
large percentage (45%) of them decided not to enroll in the study by
declining participation after the screening process or by not attending their
scheduled baseline interview. The results indicated that social stability, as
well as ethnic group were associated with treatment participation. In
particular, individuals who chose not to participate, were more likely to have
moved recently, be unmarried, unemployed, younger, and less educated
compared to those who did come in for treatment. This may be related to
the participants’ readiness to change, maturity, or other competing life
stressors.
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African Americans were also less likely to enter into treatment than
Hispanics or Whites. There was an effort to recruit minority research
assessors and therapists at the treatment sites. However, there were no
African American research staff at the Farmington site where most of the
African American volunteers were screened, perhaps decreasing the comfort
level needed for the initial steps to begin treatment. Treatment that is
culturally competent and sensitive has been an important and growing
concern in the area of substance abuse treatment (Copeland, 1997).
Other variables associated with the decision to participate included
individuals’ own beliefs about their marijuana dependence. Those who did
not believe that they were dependent on marijuana were less likely to
participate. Theoretically, some of these volunteers may not actually have
been dependent on marijuana. For others, perhaps there was an initial
interest in treatment, some contemplation, but ambivalence about taking
action in committing to therapy (Prochaska & DiClemente, 1983). Because
dependence on another drug or alcohol was an exclusion criterion, co-
morbid drug use was not a significant factor among study participants.
However, those who were heavier drinkers (i.e., more alcohol
drinks/drinking day), as well as users of sedatives or cocaine were less likely
to participate beyond the screening interview. These data suggest that
although those who chose not to participate were not necessarily dependent
on alcohol or other drugs, their substance use pattern indicated they might
be more severe or likely to be at risk of abusing other substances.
The examination of social stability, ethnic and educational barriers to
participation in treatment as well as assessment of individuals’ commitment
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or motivation to change behaviors early in the treatment process, may be an
integral part of designing programs which encourage treatment initiation
and subsequent attendance.
5.3. Consequences ofMarijuana Dependence. Despite the fact that
MTP participants appeared to function well in society (i.e., most were
working, educated, had a stable living environment), perpetuating the myth
that marijuana is a benign drug, they experienced many problems related to
their use. The sample reported experiencing an average of 80% of the DSM-
IV dependence criteria, and nearly all participants (95%) reported that they
did not stop using despite knowing that it caused persistent or recurrent
psychological or physiological problems. Study participants reported being
high most of the day (more than six hours), and smoking almost every day of
the week. These data highlight the chronicity of the problem for individuals
who have been without the aid of prior treatment interventions. In addition,
this evidence helps to demonstrate that some individuals develop a chronic
use pattern which is connected with recurrent psychological, social and
physical problems that may be sustained by an underlying dependence
syndrome. It is likely that these individuals would function at an even
higher level in society without the problems caused by their marijuana
dependence.
Another myth is that marijuana use is not associated with hazardous
risk situations. However, data from MTP indicate that individuals, who
smoke for a large portion of every day, are likely to put themselves or others
at risk. Many subjects were under the influence of marijuana while driving,
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taking care of children, and working, despite endorsing problems associated
with cognitive functioning.
5. 4. Other Severity Indices. Though men and women were not found
to differ significantly in their marijuana use, women scored higher on many
of the Addiction Severity Indices. They reported experiencing more
psychiatric, medical, employment, and drug-related problems. In addition,
they reported higher depression scores on the BDI than did men in the
sample. However, women historically tend to report emotional and medical
problems more frequently than do men, and studies have shown that women
in general tend to have higher mean BDI scores than men (Beck, Steer, &
Garbin, 1988). It should also be noted that the mean BDI scores for both
men and women represent only mild clinical depression.
Overall, the scores for the psychiatric, medical, and drug composite
scores appear to be consistent with published ASI score means for other
drug and alcohol abusing samples. For the ASI in general, women typically
score higher on the psychiatric composite score, as these data show, but the
means for the other indices vary according to the drug of abuse. This
sample of marijuana-dependent women scored significantly higher on all of
the composite scores. One interesting note is that the Employment
composite score overall is lower for this sample than is typically seen for ASI
means (McLellan et al., 1992). This finding is constant with the notion that
marijuana "works" (nearly 70% of the sample are employed full time).
However, that is not to say that these individuals might be more productive
if not for their chronic use.
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The ASI Employment scale scores also indicated that African
Americans in this study experienced more employment problems than did
Whites or Hispanics. These important issues may be addressed in treatment
programs that employ case management as a component of the therapy.
Other findings across ethnicity, which may be useful, include differences in
age of problem use. Though Hispanics do not tend to begin their marijuana
use career at an earlier age, they report problems attributable to their use at
an earlier age than Whites or African Americans. It may be important for
treatment outreach programs to specifically target younger Hispanics.
Although an effort was made to recruit and serve under-employed
individuals, this study initiative was met with moderate success.
Differences across employment however, were detected, particularly in the
psychiatric severity measures. For instance individuals who were employed
full time tended to be less depressed, have a lower anxiety level, and fewer
psychiatric problems than those who were employed part time, or not at all.
Again, the BDI scores fall in the high normal range. Yet, with regard to the
Anxiety Inventory, even though full time employees scored lower than the
those who were underemployed, all groups reported higher means than the
average working adult, indicating that perhaps the level of anxiety overall is
elevated for these marijuana-dependent individuals. Unemployed
participants also sought substantially more medical care than full time
employed individuals in the study, and they scored higher on the ASI
Medical composite score. The tendency for underemployed individuals to
present for treatment with a more severe medical and psychiatric profile
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than those who are employed may increase the likelihood that overcoming
dependence will be a difficult challenge for these more severe individuals.
5.5. Summary. In summary, data from the Marijuana Treatment
Project will provide information to the research and treatment community
relevant to designing marijuana-specific treatment programs and enhancing
treatment access. The demographic and clinical characteristics outlined in
this paper are consistent with previous studies in showing that there is a
group of marijuana-dependent individuals who are seeking marijuana-
specific treatment for their addiction. It is also important to note that there
are a significant number of individuals who experience barriers to treatment,
which, if addressed by providers, may increase treatment access.
The study initiative to recruit a larger, more diverse sample of chronic
marijuana users as well as women was met with good success allowing
generalizability to a more heterogeneous group. Because these data are
derived from a research study, individuals were excluded for reasons that
would not preclude them from entering a substance abuse treatment
program. Therefore, individuals with co-morbid addictions, severe
psychiatric status or court-mandated treatment should also be considered in
planning strategies to increase treatment access.
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APPENDICES
Table 1: Baseline Assessments
Assessment Purpose
The Quick Screen
SCID Alcohol and Drug Modules
Time-Line Follow Back Calendar
for Marijuana Use
Treatment Utilization
Questionnaire
Addiction Severity Index
State Trait Anxiety (Y-1)
Beck Depression Inventory
Marijuana Problem Scale
Basic demographics, inclusion and
exclusion criteria
DSM-IV criteria for alcohol and drug
abuse and dependence
Quantity & frequency of marijuana
use, and use in hazardous situations
Utilization of medical, psychiatric,
and other social services, as well as
use of medications
Severity of drug, alcohol, medical,
employment, legal, psychiatric, and
social problems based on composite
scores
State anxiety level
Level of depression
Number of marijuana problems
endorsed
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Table 2" Demographic Characteristics From the Quick Screen,
Eligible Screened Sample
Characteristic
Gender
Male
Female
Ethnic Group
White
Hispanic
African American
Other
Marital Status
Married/Cohabiting
Not Married
Living Situation
Own/Family Owns
Apartment/Rent
Room/Shelter/Halfway House/No
Fixed Address
Employment Status
Full Time
Part Time
Unemployed
Student/Retired/Homemaker
% of Sample
N=813
67.9
32.1
65.1
16.5
15.6
2.9
35.4
64.6
41.6
56.1
63.5
14.1
16.3
6.1
Characteristic Mean (SD)
Age
Years ofEducation
Years at Present Job
35.07 (8.77)
13.72 (2.11}
4.64 (5.69)
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Table 3: Alcohol and Drug Use Characteristics From the Quick Screen,
Eligible Screened Sample
Characteristic
Are you currently dependent on marijuana?
No
Yes
Don’t know
Have you everfelt dependent on alcohol?
No
Yes
Don’t know
Have you everfelt dependent on another drug?
No
Yes
Don’t know
Which substance is the biggest problem for
you now?
Marijuana
Alcohol
Other Drugs
% of Sample
N=813
5.8
87.1
7.2
82.4
16.4
1.3
78.2
21.6
.2
99.0
.6
.4
Characteristic Mean (SD)
Days used marijuana (ofthe past 90 days)
Times per day smoked marijuana
Days since last smoking episode
Alcohol drinks per drinking day
High alcohol drinking days (>5 drinks) in the
past month
Days (past 30) used sedatives
Days (past 30)used opiates
Days (past 30} used cocaine
Days (past 30) used stimulants
Days (past 30)used heroin
Days (past 30) used other drugs
81.28 (14.74)
3.77 (1.67)
1.33 (3.14)
2.04 (2.06)
.93 (2.40)
.20 (1.38)
11 (.84)
.20 (1.13)
.04 (.32)
.o2 (.s3)
i i (.88)
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Table 4: Psychiatric Characteristics From the Quick Screen,
Eligible Screened Sample
Characteristic
Are you currently receiving treatment for a
psychiatric problem?
No
Yes
Have you ever been hospitalized for a
psychiatric problem?
No
Yes
Have you had serious thoughts ofsuicide in
the past 90 days?
No
Yes
% of Sample
N=813
91.7
8.3
92.5
7.5
93.7
6.3
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Table 5: Demographic Characteristics From the Quick Screen,
Significant Findings; Eligible Screened Sample by Study
Participation
Characteristic
Ethnic Group
White
Hispanic
African American
Other
Marital Status
Married/Cohabiting
Not Married
Living Situation
Own/Family Owns
Apartment/Rent
Room/ Shelter/ Halfway
House/No Fixed Address
Employment Status
Full Time
Part Time
Unemployed
Student/Retired/Home-
maker
% No Show
or Declined
Participation
N=363
59.7
15.6
20.2
4.5
29.2
70.8
36.4
61.6
56.3
14.2
21.3
% MTP
Participant
N=450
69.3
17.1
12.0
1.6
40.2
59.8
45.8
51.8
69.1
14.0
12.4
17.72
10.56
7.82
19.30
Sig.
.001
.001
.020
.000
Characteristic Mean (SD) Mean (SD) Sig.
Age
Years ofEducation
Years at Present Job
Times Moved in the Past Year
33.78 (9.14)
13.30 (2.10)
4.04 (5.57)
.78 (1.22)
36.08 (8.34)
14.04 (2.07)
5.03 (5.74)
.47 (.89)
-3.69
-5.03
-2.13
4.00
.000
.000
.033
.000
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Table 6: Alcohol and Drug Use Characteristics From the Quick Screen,
Significant Findings; Eligible Screened Sample by Study
Participation
Characteristic
Are you currently dependent on
marijuana?
No
Yes
Don’t know
% No Show
or Declined
Participation
N=363
9.7
81.4
8.9
% MTP
Participant
N=450
2.7
91.6
5.8
2 Sig.
22.10 .000
Characteristic Mean (SD) Mean (SD) Sig.
Alcohol drinks per drinking day
Days (past 30) used sedatives
Days (past 30)used cocaine
2.29 (2.34)
.33 (1.99)
.35 (1.62)
1.85 (1.80)
.o9
.08 (.44)
2.94
2.20
3.02
.003
.029
.003
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Table 7: SCID Dependence Symptoms,
Percent of MTP Participants Who Endorsed Each Symptom
Symptom Description
Tolerance: The need to smoke more
marijuana in order to get high or reach a
desired effect.
Withdrawal: The presence of marijuana-
specific withdrawal symptoms as the
result of stopping or reducing use.
Compulsion: Using for a longer period of
time than intended, or using more than
you were planning to.
Compulsion: Much time spent
buying/using/recovering from the effects
of marijuana.
Readdiction Liability: Many unsuccessful
attempts to quit or cut down.
Salience: Using takes up the time
normally spent on other important
activities.
Salience: Using despite persistent or
recurrent psychological or physical
problems cause by marijuana.
% of Sample
N=450
68.2
77.6
76.9
83.3
96.0
64.2
95.1
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Table 8: Marijuana Problem Items,
Percent of MTP Participants Who Endorsed Each Item
Item Stem
Has marijuana use caused you:
% of Sample
N=450
To feel bad about your use 90.2
To have lower energy level 86.0
To procrastinate 86.0
Memory loss 76.4
To have lower productivity 75.1
Lowered self-esteem 74.2
To lack self-confidence 68.4
Withdrawal symptoms 61.1
Problems between you and your partner 58.0
Financial difficulties 48.9
Difficulty sleeping 46.0
Problems in your family 44.4
To neglect your family 38.7
Medical problems 33.6
Problems between you and your friends 26.4
To miss days at work or miss classes 19.8
To lose a job 8.2
Blackouts or flashbacks 7.6
Legal problems 7.1
Total Mean (SD)
Mean number of problems endorsed
(of 19) 9.59 (3.56)
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Table 9" Hazardous Use (in the past 90 days),
Percent of MTP Participants
Hazard Stem-
Used marijuana within one hour prior to...
...driving a vehicle
Never
Less than weekly
Weekly
Less than daily
Daily (or almost daily}
taking care ofchildren
Never
Less than weekly
Weekly
Less than daily
Daily (or almost daily)
...operating dangerous equipment
Never
Less than weekly
Weekly
Less than daily
Daily (or almost daily)
...working on a paidjob
Never
Less than weekly
Weekly
Less than daily
Daily (or almost daily)
...playing sports or recreating
Never
Less than weekly
Weekly
Less than daily
Daily (or almost daily)
% of Sample
N=450
12.7
8.2
11.1
13.8
54.1
66.1
8.7
4.7
3.3
17.2
39.9
12.0
9.8
7.8
30.5
33.8
12.1
7.5
6.4
40.2
30.1
16.0
22.0
12.2
19.6
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Table 10"Treatment and Medication Utilization, and Severity Measures,
Significant Findings; MTP Participants by Gender
Variable
Psychiatc Co osite Score (ASI)
dicat Co osite Score SI)
E toyment Composite ore
(ASI)
Dmg osite ore (ASI)
Beck Dression ore
Days with a counselorfor
for a
Ds on medicationar a
pbte
Mean (SD)
Male Female
N=308 N=142
.13 .19
(.17) (.19) -3.21 .001
.24
10.85
.27
(.30)
12.74
-2.03 .043
-3.16 O
-2.34 .0
-2.38 .018
.53
(1.97) -2.13 034
14.20
(30i64) -2.68 .008
in the past 90 days
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Table 11"Alcohol and Drug Use, Medications, and Severity Measures,
Significant Findings; MTP Participants by Ethnicity
riable
Days used ma ana
urs you
.Felt h per day
anda alcohol dn you
d on a tical dnki
79.40 75.47 83.17
7.04
(4.89)
.010
Days used other dmgs
.42 1.78
on medications fir a
pmbte
4.65 .010
114.55
"Others" [n=5] removed from analyses
in the past 90 days
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Table 12:Medical Care and Severity Measures,
Significant Findings; MTP Participants by Employment Status
Variable
Days seen for medical care
dical Composite Score
(ASI)
ck Depression re
ate A ety Score
ana Problem ore
ychiatc Co osite re
tment Co osite
ore
Mean (SD)
- -
Unem-
tie
N=311
1.79
.20
(.27)
10.63
2 27 7.08
(3.)
.24 .43
12.07 !5.52
38.42 42.10 43.94
9.23 10,57 10.48
(3.40) (3.67)
.13 19 ,24
(.18) (.22
.12"24..000
.14 .31 .53
RetiredIn=20] removed from the analyses
in the past 90 days



